These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 32618256

  • 1. Seroprevalence of Measles, Rubella, Tetanus, and Diphtheria Antibodies among Children in Haiti, 2017.
    Minta AA, Andre-Alboth J, Childs L, Nace D, Rey-Benito G, Boncy J, Adrien P, Francois J, Phaïmyr Jn Charles N, Blot V, Vanden Eng J, Priest JW, Rogier E, Tohme RA.
    Am J Trop Med Hyg; 2020 Oct; 103(4):1717-1725. PubMed ID: 32618256
    [Abstract] [Full Text] [Related]

  • 2. Seroprevalence of chronic hepatitis B virus infection and immunity to measles, rubella, tetanus and diphtheria among schoolchildren aged 6-7 years old in the Solomon Islands, 2016.
    Breakwell L, Anga J, Cooley G, Ropiti L, Gwyn S, Wannemuehler K, Woodring J, Ogaoga D, Martin D, Patel M, Tohme RA.
    Vaccine; 2020 Jun 19; 38(30):4679-4686. PubMed ID: 32473876
    [Abstract] [Full Text] [Related]

  • 3. Seroprevalences of antibodies against pertussis, diphtheria, tetanus, measles, mumps and rubella: A cross-sectional study in children following vaccination procedure in Guangzhou, China.
    Li YT, Luo XQ, Zhong XB, Cai LM, Zhu LP, Chen XQ, Wang KC, Chen ZG.
    Vaccine; 2020 May 13; 38(23):3960-3967. PubMed ID: 32321685
    [Abstract] [Full Text] [Related]

  • 4. Haiti 2007-2008 national measles-rubella vaccination campaign: implications for rubella elimination.
    Rainey JJ, Danovaro-Holliday MC, Magloire R, Kananda G, Lee CE, Chamouillet H, Lacapere F, Mung K, Luman ET.
    J Infect Dis; 2011 Sep 01; 204 Suppl 2():S616-21. PubMed ID: 21954256
    [Abstract] [Full Text] [Related]

  • 5. Are we hitting immunity targets? The 2006 age-specific seroprevalence of measles, mumps, rubella, diphtheria and tetanus in Belgium.
    Theeten H, Hutse V, Hens N, Yavuz Y, Hoppenbrouwers K, Beutels P, Vranckx R, Van Damme P.
    Epidemiol Infect; 2011 Apr 01; 139(4):494-504. PubMed ID: 20587123
    [Abstract] [Full Text] [Related]

  • 6. The use of rapid coverage monitoring in the national rubella vaccination campaign, Haiti 2007-2008.
    Lacapère F, Magloire R, Danovaro-Holliday MC, Flannery B, Chamoulliet H, Celestin EP.
    J Infect Dis; 2011 Sep 01; 204 Suppl 2():S698-705. PubMed ID: 21954269
    [Abstract] [Full Text] [Related]

  • 7. Expansion of Vaccination Services and Strengthening Vaccine-Preventable Diseases Surveillance in Haiti, 2010-2016.
    Tohme RA, Francois J, Cavallaro KF, Paluku G, Yalcouye I, Jackson E, Wright T, Adrien P, Katz MA, Hyde TB, Faye P, Kimanuka F, Dietz V, Vertefeuille J, Lowrance D, Dahl B, Patel R.
    Am J Trop Med Hyg; 2017 Oct 01; 97(4_Suppl):28-36. PubMed ID: 29064356
    [Abstract] [Full Text] [Related]

  • 8. Vaccination coverage survey and seroprevalence among forcibly displaced Rohingya children, Cox's Bazar, Bangladesh, 2018: A cross-sectional study.
    Feldstein LR, Bennett SD, Estivariz CF, Cooley GM, Weil L, Billah MM, Uzzaman MS, Bohara R, Vandenent M, Adhikari JM, Leidman E, Hasan M, Akhtar S, Hasman A, Conklin L, Ehlman D, Alamgir A, Flora MS.
    PLoS Med; 2020 Mar 01; 17(3):e1003071. PubMed ID: 32231368
    [Abstract] [Full Text] [Related]

  • 9. Age-stratified seroprevalence of vaccine-preventable infectious disease in Saravan, Southern Lao People's Democratic Republic.
    Xaydalasouk K, Sayasinh K, Hübschen JM, Khounvisith V, Keomany S, Muller CP, Black AP.
    Int J Infect Dis; 2021 Jun 01; 107():25-30. PubMed ID: 33864919
    [Abstract] [Full Text] [Related]

  • 10. Measles and rubella vaccination coverage in Haiti, 2012: progress towards verifying and challenges to maintaining measles and rubella elimination.
    Tohme RA, François J, Wannemuehler K, Magloire R, Danovaro-Holliday MC, Flannery B, Cavallaro KF, Fitter DL, Purcell N, Dismer A, Tappero JW, Vertefeuille JF, Hyde TB.
    Trop Med Int Health; 2014 Sep 01; 19(9):1105-15. PubMed ID: 25041586
    [Abstract] [Full Text] [Related]

  • 11. Factors associated with non-uptake of measles-rubella vaccine second dose among children under five years in Mtwara district council, Tanzania, 2017.
    Magodi R, Mmbaga EJ, Massaga J, Lyimo D, Mphuru A, Abade A.
    Pan Afr Med J; 2019 Sep 01; 33():67. PubMed ID: 31448029
    [Abstract] [Full Text] [Related]

  • 12. Use of the revised World Health Organization cluster survey methodology to classify measles-rubella vaccination campaign coverage in 47 counties in Kenya, 2016.
    Subaiya S, Tabu C, N'ganga J, Awes AA, Sergon K, Cosmas L, Styczynski A, Thuo S, Lebo E, Kaiser R, Perry R, Ademba P, Kretsinger K, Onuekwusi I, Gary H, Scobie HM.
    PLoS One; 2018 Sep 01; 13(7):e0199786. PubMed ID: 29965975
    [Abstract] [Full Text] [Related]

  • 13. Age-specific prevalence of IgG against measles/rubella and the impact of routine and supplementary immunization activities: A multistage random cluster sampling study with mathematical modelling.
    Hachiya M, Vynnycky E, Mori Y, Do HT, Huynh MK, Trinh LH, Nguyen DD, Tran NAT, Hoang TT, Hoang HHT, Vo NDT, Le TH, Ichimura Y, Miyano S, Okawa S, Thandar MM, Yokobori Y, Inoue Y, Mizoue T, Takeda M, Komada K.
    Int J Infect Dis; 2024 Jul 01; 144():107053. PubMed ID: 38641317
    [Abstract] [Full Text] [Related]

  • 14. Seroprevalence of measles and rubella antibodies in pregnant women Haiti, 2012.
    Fitter DL, Anselme R, Paluku G, Rey G, Flannery B, Tohme RA, Marston BJ, Griswold M, Boncy J, Vertefeuille JF.
    Vaccine; 2013 Dec 17; 32(1):69-73. PubMed ID: 24188751
    [Abstract] [Full Text] [Related]

  • 15. Impact of a Measles and Rubella Vaccination Campaign on Seroprevalence in Southern Province, Zambia.
    Carcelen AC, Mutembo S, Matakala KH, Chilumba I, Mulundu G, Monze M, Mwansa FD, Moss WJ, Hayford K.
    Am J Trop Med Hyg; 2021 May 03; 104(6):2229-2232. PubMed ID: 33939639
    [Abstract] [Full Text] [Related]

  • 16. Serosurveillance of vaccine preventable diseases and hepatitis C in healthcare workers from Lao PDR.
    Black AP, Vilivong K, Nouanthong P, Souvannaso C, Hübschen JM, Muller CP.
    PLoS One; 2015 May 03; 10(4):e0123647. PubMed ID: 25874696
    [Abstract] [Full Text] [Related]

  • 17. Seroprevalence of measles, mumps and rubella among children in American Samoa, 2011, and progress towards West Pacific Region goals of elimination.
    Mahamud A, Masunu-Faleafaga Y, Walls L, Williams N, Garcia P, Teshale E, Williams R, Dulski T, Bellini WJ, Kutty PK.
    Vaccine; 2013 Aug 12; 31(36):3683-7. PubMed ID: 23770334
    [Abstract] [Full Text] [Related]

  • 18. Fully vaccinated children are rare: immunization coverage and seroprevalence in Austrian school children.
    Ringler M, Göbel G, Möst J, Weithaler K.
    Eur J Epidemiol; 2003 Aug 12; 18(2):161-70. PubMed ID: 12733839
    [Abstract] [Full Text] [Related]

  • 19. Parental Vaccine Hesitancy and Association With Childhood Diphtheria, Tetanus Toxoid, and Acellular Pertussis; Measles, Mumps, and Rubella; Rotavirus; and Combined 7-Series Vaccination.
    Nguyen KH, Srivastav A, Lindley MC, Fisher A, Kim D, Greby SM, Lee J, Singleton JA.
    Am J Prev Med; 2022 Mar 12; 62(3):367-376. PubMed ID: 35190101
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of nationwide supplementary immunization in Lao People's Democratic Republic: Population-based seroprevalence survey of anti-measles and anti-rubella IgG in children and adults, mathematical modelling and a stability testing of the vaccine.
    Hachiya M, Miyano S, Mori Y, Vynnycky E, Keungsaneth P, Vongphrachanh P, Xeuatvongsa A, Sisouk T, Som-Oulay V, Khamphaphongphane B, Sengkeopaseuth B, Pathammavong C, Phounphenghak K, Kitamura T, Takeda M, Komase K.
    PLoS One; 2018 Mar 12; 13(3):e0194931. PubMed ID: 29596472
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.